Dated disclosed rounds · latest 2022-01-01
Later stage / growth
iProov
Biometric identity verification
- Companies House
- 07866563
- GLEIF LEI
- 213800I9QMCDH747UG69
- Latest evidence
- 2022-01-01
- Evidence snapshot
- 2026-08-25
Exact award notices · latest 2026-03-17
2026-08-01
Jun 2026
Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.
Evidence timeline
7 dated observations
Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.
RegistryRecord observation Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
ProcurementSource fact Biometric Remote Enrolment Trials
Home Office · £75,000 notice value
ProcurementSource fact AoF UK Border Trials
Home Office · £8,000,000 notice value
IdentifierReference metadata LEI record updated
213800I9QMCDH747UG69 · registration ISSUED
IdentifierReference metadata LEI first registered
213800I9QMCDH747UG69
FundingSource fact Series C
$70M · 1 named investor
RegistryRegistry fact Company incorporated
IPROOV LIMITED · company 07866563
Latest disclosed round
Growth round (widely reported as Series C; exact letter unconfirmed in sources reviewed)
- Date
- 2022-01-01
- Amount
- USD 70m
- Sector
- Cybersecurity
- Companies House
- 07866563
- ONS region
- London
Evidence status
Directory ready
- Identity
- Verified
- Match
- High — exact company number and aligned registered name
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
1 linked investor
Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.
| Investor | Role | Date | Source | Match / state |
|---|---|---|---|---|
| Sumeru Equity Partners | lead | 2022-01-01 | TechCrunch ↗ · Iproov ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
Funding record
1 disclosed round
Open a dated round to move directly between the company, named investors and source publication.
| Date | Stage | Amount | Investors | Named sources |
|---|---|---|---|---|
| 2022-01-01 | Series C | $70M | Sumeru Equity Partners | TechCrunch ↗ · Iproov ↗ |
Companies House status and filing snapshot
IPROOV LIMITED
Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.
Registered record
- Status
- Active
- Company type
- Private Limited Company
- Country of origin
- United Kingdom
- Incorporated
- 2011-11-30
- Dissolved
- Not applicable
- Company number
- 07866563
Filing context
- Accounts category
- GROUP
- Accounts made up to
- 2024-12-31
- Next accounts due
- 2026-09-30
- Confirmation made up to
- 2025-11-13
- Registry snapshot
- 2026-08-01
- Live check
- Bulk snapshot only
Global legal-entity identifier
213800I9QMCDH747UG69
Exact company-number match to the GLEIF golden-copy data. An LEI is an identifier for a legal entity; it is not a credit, risk or investment-quality rating.
GLEIF record
- Legal name
- IPROOV LIMITED
- Entity status
- ACTIVE
- Jurisdiction
- GB
- Registration status
- ISSUED
- Last updated
- 2025-12-04T12:09:12.630Z
- Next renewal
- 2027-01-29T00:00:00Z
Public-sector traction
2 matched award notices
Exact Companies House-number matches from Contracts Finder. Values are notice values, not recognised revenue.
| Published | Buyer | Award | Notice value | Source |
|---|---|---|---|---|
| 2026-03-17 | Home Office | Biometric Remote Enrolment Trials | £75,000 | Contracts Finder ↗ |
| 2026-03-12 | Home Office | AoF UK Border Trials | £8,000,000 | Contracts Finder ↗ |
Traceability
Source trail
Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.